Stocktwits on MSN
ATOS stock jumps 8% today – an FDA designation draws investor cheer for Atossa Therapeutics
The RPD designation is given to therapies targeting serious or life-threatening conditions that primarily affect children. ・(Z)-endoxifen already has an RPD designation for the treatment of Duchenne ...
Stocktwits on MSN
Atossa Therapeutics stock jumps after FDA grants rare pediatric status to DMD drug — retail bets on phase 3 fast-track
The FDA designation expands Atossa’s investigational therapy into rare pediatric neuromuscular disease. ・The program could become eligible for a Priority Review Voucher upon future approval.
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Atossa Genetics Inc. (ATOS) one of those stocks right now? By ...
Atossa Therapeutics (NASDAQ:ATOS) shares were up 16% in midday trading Friday after Cantor Fitzgerald initiated coverage of the company with an overweight rating, citing upcoming data readouts for its ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Atossa's stock price was trading ...
SEATTLE, June 27, 2023 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (ATOS) (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative proprietary medicines to address ...
Atossa Therapeutics Inc. ATOS shares are trading higher Monday after the company announced it will release the final data from its Phase 2 study of endoxifen administered to breast cancer patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results